Metoprolol for Atrial Fibrillation: Rate Control Guide (2026)

What Is Rate Control in Atrial Fibrillation?

Atrial fibrillation (AFib) causes the upper chambers of the heart to beat chaotically, often driving the ventricles (lower chambers) to beat too fast — sometimes over 150 beats per minute. This rapid ventricular rate can cause symptoms (palpitations, shortness of breath, fatigue) and, over time, can weaken the heart muscle (tachycardia-induced cardiomyopathy).

Rate control therapy slows the ventricular rate to a target of 60–100 beats per minute at rest (lenient rate control: <110 bpm at rest is also acceptable per RACE II trial). Metoprolol is one of the most commonly used rate control agents.

How Metoprolol Controls the Heart Rate in AFib

Metoprolol blocks beta-1 adrenergic receptors in the AV node (the electrical gateway between the atria and ventricles), slowing conduction through the AV node and reducing the number of atrial impulses that reach the ventricles. This slows the ventricular rate without converting the rhythm back to normal sinus rhythm.

Dosing for Rate Control in AFib

Formulation	Acute Rate Control	Chronic Rate Control
Metoprolol tartrate (IV)	2.5–5 mg IV over 2 minutes; repeat every 5 minutes × 3 doses as needed	N/A (IV for acute use only)
Metoprolol tartrate (PO)	25–100 mg every 6–12 hours	25–200 mg twice daily
Metoprolol succinate (ER)	Not used for acute rate control	25–200 mg once daily

Metoprolol vs Other Rate Control Options

Drug	Mechanism	Advantages	Disadvantages
Metoprolol	Beta-1 blocker	Preferred in HFrEF; good for exercise-induced rate increase; once daily (ER)	Bronchospasm risk in asthma; fatigue; sexual dysfunction
Diltiazem	Non-dihydropyridine CCB	Effective rate control; less fatigue than [beta-blockers](/drug-classes/beta-blockers)	Contraindicated in HFrEF; drug interactions
Verapamil	Non-dihydropyridine CCB	Effective rate control	Contraindicated in HFrEF; more drug interactions than diltiazem
Digoxin	Vagal tone enhancement	Useful in HFrEF; does not cause hypotension	Poor rate control during exercise; narrow therapeutic index; toxicity risk
Amiodarone	Multiple mechanisms	Effective when others fail	Significant toxicity (thyroid, lung, liver); last resort for rate control

When Is Metoprolol the Best Choice?

AFib with [heart failure](/conditions/heart-failure) with reduced ejection fraction (HFrEF) — [metoprolol](/drugs/metoprolol) succinate is the preferred rate control agent (diltiazem and verapamil are contraindicated in HFrEF)
AFib with [hypertension](/conditions/hypertension) — metoprolol addresses both conditions
AFib with exercise-induced rate increase — beta-blockers are more effective than digoxin at controlling exercise heart rate
Post-MI AFib — metoprolol has additional cardioprotective benefit

Rate Control vs Rhythm Control

Rate control and rhythm control (restoring normal sinus rhythm with antiarrhythmic drugs or cardioversion) are both acceptable strategies for AFib management. The AFFIRM trial (2002) showed no mortality difference between the two strategies. However, the EAST-AFNET 4 trial (2020) showed that early rhythm control (within 1 year of AFib diagnosis) reduced cardiovascular events by 21% compared to rate control. Current guidelines favor early rhythm control for eligible patients, particularly those with recent-onset AFib.

References

Wyse DG, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation (AFFIRM). N Engl J Med. 2002;347(23):1825-1833.
Kirchhof P, et al. Early rhythm-control therapy in patients with atrial fibrillation (EAST-AFNET 4). N Engl J Med. 2020;383(14):1305-1316.
Van Gelder IC, et al. Lenient versus strict rate control in patients with atrial fibrillation (RACE II). N Engl J Med. 2010;362(15):1363-1373.

Metoprolol for Atrial Fibrillation: Rate Control, Dosing, and Alternatives